Detection of proliferating cell nuclear antigens and interleukin-2 beta receptor molecules on mitogen- and

J Hesketh1, D Dobbelaere, J F Griffin

  • 1Department of Microbiology, University of Otago, Dunedin, New Zealand.

Immunology
|July 1, 1993
PubMed

Insights

Proliferating cell nuclear antigen (PCNA) is a more accurate marker for lymphocyte activation than interleukin-2 receptors (IL-2R) in deer. PCNA reliably identifies antigen-reactive cells in deer exposed to Mycobacterium bovis.

Area of Science:

  • Veterinary Immunology
  • Cellular Immunology
  • Biomarker Discovery

Background:

  • Lymphocyte activation is crucial for adaptive immunity.
  • Identifying reliable markers for lymphocyte activation is essential for disease monitoring.
  • Interleukin-2 receptors (IL-2R) and proliferating cell nuclear antigens (PCNA) are potential markers.

Purpose of the Study:

  • To compare the efficacy of IL-2R and PCNA as markers of lymphocyte activation in deer.
  • To evaluate their utility in identifying antigen-specific immune responses.

Main Methods:

  • Deer lymphocytes were activated using mitogen (Concanavalin A) and antigen (Mycobacterium bovis-derived purified protein derivative - PPD).
  • Expression of IL-2R and PCNA was detected using heterologous polyclonal and monoclonal antibodies, respectively.
  • Lymphocyte transformation (LT) activity was used as a measure of activation.

Main Results:

  • Both IL-2R and PCNA were co-expressed on mitogen-activated blast cells.
  • PCNA expression more accurately reflected both antigen- and mitogen-induced lymphocyte activation compared to IL-2R.
  • PCNA expression successfully identified antigen-reactive cells in M. bovis-exposed deer, with significantly higher levels in infected animals.

Conclusions:

  • PCNA is a superior and more reliable biomarker for assessing lymphocyte activation and antigen-specific responses in deer.
  • PCNA can be effectively used to detect cellular immune responses to M. bovis infection.

Related Concept Videos